Annamycin is potentially a highly versatile drug capable of working synergistically with numerous mechanistically different ...

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new ...

Medicare Part D, an optional component of Medicare, helps beneficiaries pay for generic and name-brand prescription drugs.  A ...

Methyl eugenol (ME) possesses significant antioxidant, anticancer and neuroprotective properties, potentially beneficial ...

There are many ways to kill microbes that cause dangerous infections. Combining genetic screening with machine learning can ...

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000—until recently. Thanks to changes in Medicare Part D ...

Northeast Ohioans are getting the opportunity to safely dispose of old or unwanted prescription or over-the-counter drugs ...

According to a new study published in BMC Cancer, “CBD demonstrated significant anticancer effects, including induction of ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway ...

Growing Pipeline of ADC Candidates for Various Cancer Indications is Driving the IndustryDublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market - Global Industry Size, Share, ...

A joint research team has developed a modular protein adapter technology that enables the stable attachment of various ...

Phenotypic screening has re-emerged as a powerful strategy for identifying drugs based on their observable effects. Discover ...